FDA Approves New Treatment for Congenital Adrenal Hyperplasia

Today, the FDA approved a new treatment to be used together with glucocorticoids (steroids) to control androgen (a testosterone-like hormone) levels in adults and pediatric patients 4 years of age and older with classic congenital adrenal hyperplasia.
Source: FDA Press Releases